Neoleukin Therapeutics Inc (NLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NLTX | AMGN | VRTX | BMY | GILD |
| Company | Neoleukin Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 13.80 | 262.11 | 408.00 | 55.68 | 90.30 |
| High | 14.36 | 270.49 | 416.55 | 55.79 | 90.37 |
| Low | 13.68 | 261.28 | 397.24 | 54.81 | 89.02 |
| Last | 13.96 | 270.19 | 413.37 | 55.36 | 89.94 |
| Change | +0.20 | +7.96 | +3.81 | -0.47 | +0.06 |
| % Change | +1.45% | +3.04% | +0.93% | -0.84% | +0.07% |
| Volume | 28,275 | 3,365,900 | 1,859,700 | 7,120,700 | 6,523,200 |
| 20-Day Average Volume | 33,865 | 3,632,655 | 2,036,440 | 11,641,665 | 6,379,650 |
| Previous Close | 13.76 | 262.23 | 409.56 | 55.83 | 89.88 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.45 | 263.63 | 420.01 | 56.74 | 91.89 |
| 20-Day Raw Stochastic | 62.00% | 74.82% | 36.87% | 14.73% | 22.91% |
| 20-Day Relative Strength | 50.56% | 45.97% | 40.61% | 44.44% | 46.30% |
| Weighted Alpha | +35.60 | -15.18 | -9.90 | +14.91 | +12.07 |
| Today's Opinion | 72% Sell | 88% Sell | 88% Sell | 40% Buy | 56% Buy |
| Previous Opinion | 96% Sell | 100% Sell | 88% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 88% Sell | 72% Sell | 8% Sell | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.29% since 12/11/23 | +3.43% since 01/03/25 | +1.54% since 01/03/25 | -2.14% since 01/03/25 | -1.61% since 01/03/25 |
| Low | 3.25 on 12/12/23 | 257.05 on 01/06/25 | 397.24 on 01/13/25 | 54.81 on 01/13/25 | 88.57 on 01/10/25 |
| High | 3.64 on 12/15/23 | 270.49 on 01/13/25 | 416.55 on 01/13/25 | 57.67 on 01/07/25 | 91.53 on 01/06/25 |
| 1-Month | |||||
| %Chg | +4.18% since 11/17/23 | -0.16% since 12/13/24 | -10.86% since 12/13/24 | -0.75% since 12/13/24 | -2.08% since 12/13/24 |
| Low | 3.18 on 11/22/23 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 54.81 on 01/13/25 | 88.57 on 01/10/25 |
| High | 3.68 on 11/30/23 | 272.69 on 12/16/24 | 474.18 on 12/17/24 | 58.54 on 12/18/24 | 94.55 on 12/26/24 |
| 3-Month | |||||
| %Chg | -9.35% since 09/18/23 | -17.71% since 10/11/24 | -14.19% since 10/11/24 | +6.05% since 10/11/24 | +5.87% since 10/11/24 |
| Low | 3.18 on 11/22/23 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 51.31 on 10/15/24 | 84.34 on 10/14/24 |
| High | 4.14 on 10/10/23 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -9.84% since 06/16/23 | -18.33% since 07/12/24 | -15.42% since 07/12/24 | +36.83% since 07/12/24 | +28.56% since 07/12/24 |
| Low | 3.05 on 08/14/23 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 39.92 on 07/15/24 | 70.21 on 07/15/24 |
| High | 4.70 on 07/17/23 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,799 | 140,957,296 | 105,473,568 | 113,233,128 | 112,014,384 |
| Shares Outstanding, K | 9,398 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -57,560,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -4,530,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.11 | 0.56 | 0.40 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.41 on 11/14/23 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/13/23 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.620 on 01/03/25 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.75 | 0.00 | 48.56 | 20.12 |